Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary

TRACON Pharmaceuticals

11/08/2021 22:17

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 58 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 31 cents per share.
* Revenue was $346.00 thousand​;  analysts expected zero. 
* TRACON Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 58 cents​.
* The mean earnings estimate of analysts had risen by about 0.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TRACON Pharmaceuticals Inc shares had fallen by 42.1% this
quarter and lost 67.9% so far this year.
* The company reported a quarterly loss of $8.94 million.
* Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:17 p.m.  ​All
figures in US dollars unless otherwise stated